Physical and functional interaction between HCV core protein and the different p73 isoforms

Oncogene

Volumn 22, Issue 17, 2003, Pages 2573-2580

  Alisi, Anna ^a   Giambartolomei, Stefania ^a,b   Cupelli, Felicia ^b   Merlo, Paola ^a   Fontemaggi, Giulia ^c   Spaziani, Alessandra ^a   Balsano, Clara ^a,b,d  

^a Fondazione Andrea Cesalpino   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

Core p53; HCC; HCV; p21WAF1 CIP1; p73

Indexed keywords

CORE PROTEIN; ISOPROTEIN; PROTEIN P53; PROTEIN P73; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DELETION MUTANT; GENE CONTROL; GROWTH INHIBITION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; VIRUS GENOME;

ACTIVE TRANSPORT, CELL NUCLEUS; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; NUCLEAR PROTEINS; OSTEOSARCOMA; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS; PAPOVAVIRIDAE; RNA VIRUSES;

EID: 0037516947     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206333     Document Type: Article

References (45)

1. Balint E, Bates S and Vousden KH. (1999). Oncogene, 18, 3923-3929.
2. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff ZS, Chapman MJ, Myamura T and Brechot C. (1997). Proc. Natl. Acad. Sci. USA, 94, 1200-1205.
3. Basu A, Meyer K, Ray RB and Ray R. (2002). Virology, 298, 53-62.
4. Colombo M. (1999). J. Hepatol., 31(Suppl 1), 25-30.
5. Costanzo A, Merlo P, Pediconi N, Fulco M, Sartorelli V, Cole PA, Fontemaggi G, Fanciulli M, Schiltz L, Blandino G, Balsano C and Levrero M. (2002). Mol. Cell, 9, 175-186.
6. De Francesco R. (1999). J. Hepatol., 31, 47-53.
7. De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annichiarico-Petruzzeli M, Levrero M and Melino G. (1998). J. Exp. Med., 188, 1763-1768.
8. Giambartolomei S, Covone F, Levrero M and Balsano C. (2001). Oncogene, 20, 2606-2610.
9. Hayashi J, Aoki H, Arakawa Y and Hino O. (1999). Intervirology, 42, 205-210.
10. Higashino F, Pipas JM and Shenk T. (1998). Proc. Natl. Acad. Sci. USA, 95, 15683-15687.
11. Jin DY, Wang HL, Zhou Y, Chun AC, Kibler KV, Hou YD, Kung H and Jeang KT. (2000). EMBO J., 19, 729-740.
12. Jost CA, Marin MC and Kaelin Jr WG. (1997). Nature, 389, 191-194.
13. Kaghad M, Bonnet H, Yang I, Creancier J, Biscan C, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, Me Keon F and Caput D. (1997). Cell, 90, 809-819.
14. Kaida A, Ariumi Y, Ueda Y, Lin JY, Hijikata M, Ikawa S and Shimotono K. (2000). Oncogene, 19, 827-830.
15. Koike K, Tsutsumi T, Fujie H, Shintani Y and Moriya K. (2002). Oncology, 62, 29-37.
16. Levrero M, De Laurenzi V, Costanzo A, Gong J, Melino G and Wang JYJ. (1999). Cell Death Differ., 6, 1146-1153.
17. Lu W, Lo S, Chen M, Wu K, Fung YK and Ou J. (1999). Virology, 264, 134-141.
18. Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R and Budkowska A. (2001). J. Virol., 75, 8240-8250.
19. Mamiya N and Worman HJ. (1999). J. Biol. Chem., 274, 15751-15756.
20. Marusawa H, Hijikata M, Chiba T and Shimotono K. (1999). J. Virol., 73, 4713-4720.
21. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T and Koike K. (1998). Nat. Med., 9, 1065-1067.
22. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T and Koike K. (1997). J. Gen. Virol., 78, 1527-1531.
23. Otsuka M, Kato N, Lan KH, Yoshida H, Kato J, Goto T, Shiratori Y and Omata M. (2000). J. Biol. Chem., 275, 34122-34130.
24. Park KJ, Choi SH, Lee SY, Hwang SB and Lai MMC. (2002). J. Biol. Chem., 277, 13122-13128.
25. Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M and El-Deiry WS. (1998). Int. J. Oncol., 13, 5-9.
26. Ray RB, Meyer K and Ray R. (1996). Virology, 226, 176-182.
27. Ray RB, Meyer K and Ray R. (2000). Virology, 271, 197-204.
28. Ray RB, Steel R, Meyer K and Ray R. (1998). Gene, 208, 331-336.
29. Reichelt M, Zang KD, Seifart M, Welter C and Ruffing T. (1999). Arch. Virol., 144, 621-626.
30. Serrano M, Lin AW, Mc Currach ME, Beach D and Lowe SW. (1997). Cell, 88, 593-602.
31. Sherr CJ and Roberts JM. (1999). Genes Dev., 13, 1501-1512.
32. Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR and Lai MM. (2002). Virology, 292, 198-210.
33. Stiewe T, Theseling CC and Putzer BM. (2002). J. Biol. Chem., 277, 14177-14185.
34. Takamatsu M, Fujita T and Hotta H. (2001). Kobe J. Med. Sci., 47, 97-112.
35. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, Mossner J, Engeland K and Wittekind C. (1999). J. Natl. Cancer, 79, 164-167.
36. Thompson EB. (1998). Annu. Rev. Physiol., 60, 575-600.
37. Tsutsumi T, Suzuki T, Shimoike T, Suzuki R, Moriya K, Shintani Y, Fujie H, Matsuura Y, Koike K and Miyamura T. (2002). Hepatology, 35, 937-946.
38. Uchida M, Hino N, Yamanaka T, Fukushima H, Imanishi T, Uchiyama Y, Kodama T and Doi T. (2002). Hepatol. Res., 22, 297-306.
39. Vossio S, Palescandolo E, Pediconi N, Moretti F, Balsano C, Levrero M and Costanzo A. (2002). Oncogene, 21, 3796-3803.
40. Wienzek S, Roth J and Dobbelstein M. (2000). J. Virol., 74, 193-202.
41. Yamanaka T, Kodama T and Doi T. (2002). Biochem. Biophys. Res. Commun., 294, 528-534.
42. You L, Chen C, Yeh T, Tsai T, Mai R, Lin C and Lee Y. (1999). J. Virol., 73, 2841-2853.
43. Zemel R, Koren C, Bachmatove L, Avigad S, Kaganovsky E, Okon E, Ben-Ari Z, Brief F, Ben-Yehoyada M, Shaul Y and Tur-kaspa R. (2002). Dig. Dis. Sci., 47, 716-722.
44. Zeng YX and Eiry WS. (1996). Oncogene, 12, 1557-1564.
45. Zhu N, Khoshan A, Schneider R, Matsumoto M, Denner G, Ware C and Lai MMC. (1998). J. Virol., 72, 3691-3697.